These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages. Majumdar S; Flasher D; Friend DS; Nassos P; Yajko D; Hadley WK; Düzgüneş N Antimicrob Agents Chemother; 1992 Dec; 36(12):2808-15. PubMed ID: 1482150 [TBL] [Abstract][Full Text] [Related]
3. Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice. Bermudez LE; Inderlied CB; Kolonoski P; Wu M; Barbara-Burnham L; Young LS Antimicrob Agents Chemother; 1996 Mar; 40(3):546-51. PubMed ID: 8851568 [TBL] [Abstract][Full Text] [Related]
4. Liposome-encapsulated antibiotics. Salem II; Flasher DL; Düzgüneş N Methods Enzymol; 2005; 391():261-91. PubMed ID: 15721386 [TBL] [Abstract][Full Text] [Related]
5. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages. Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107 [TBL] [Abstract][Full Text] [Related]
6. Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection. Mehta RT Antimicrob Agents Chemother; 1996 Aug; 40(8):1893-902. PubMed ID: 8843300 [TBL] [Abstract][Full Text] [Related]
7. Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides. Bermudez LE; Yau-Young AO; Lin JP; Cogger J; Young LS J Infect Dis; 1990 Jun; 161(6):1262-8. PubMed ID: 2345306 [TBL] [Abstract][Full Text] [Related]
8. Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes. Gangadharam PR; Ashtekar DR; Flasher DL; Düzgüneş N Antimicrob Agents Chemother; 1995 Mar; 39(3):725-30. PubMed ID: 7793880 [TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin. Yajko DM; Sanders CA; Nassos PS; Hadley WK Antimicrob Agents Chemother; 1990 Dec; 34(12):2442-4. PubMed ID: 2088204 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Mycobacterium avium-intracellulare complex infection in beige mice with free and liposome-encapsulated streptomycin: role of liposome type and duration of treatment. Düzgüneş N; Ashtekar DR; Flasher DL; Ghori N; Debs RJ; Friend DS; Gangadharam PR J Infect Dis; 1991 Jul; 164(1):143-51. PubMed ID: 2056201 [TBL] [Abstract][Full Text] [Related]
11. [Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi]. Gevaudan MJ; Bollet C; Mallet MN; de Lamballerie X; Sambuc R; de Micco P Pathol Biol (Paris); 1992 May; 40(5):443-9. PubMed ID: 1323093 [TBL] [Abstract][Full Text] [Related]
12. Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells. Bermudez LE; Young LS; Inderlied CB Antimicrob Agents Chemother; 1994 May; 38(5):1200-2. PubMed ID: 8067766 [TBL] [Abstract][Full Text] [Related]
13. Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection. Oh YK; Nix DE; Straubinger RM Antimicrob Agents Chemother; 1995 Sep; 39(9):2104-11. PubMed ID: 8540724 [TBL] [Abstract][Full Text] [Related]
14. Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages. Perronne C; Gikas A; Truffot-Pernot C; Grosset J; Vilde JL; Pocidalo JJ Antimicrob Agents Chemother; 1991 Jul; 35(7):1356-9. PubMed ID: 1656860 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the activity of fluoroquinolones against Mycobacterium avium in cell-free systems and a human monocyte in-vitro infection model. Shiratsuchi H; Jacobs MR; Pearson AJ; Venkataprasad N; Klopman G; Ellner JJ J Antimicrob Chemother; 1996 Mar; 37(3):491-500. PubMed ID: 9182106 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of liposome-encapsulated kanamycin against Mycobacterium intracellulare infection induced in mice. Tomioka H; Saito H; Sato K; Yoneyama T Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):575-9. PubMed ID: 1892297 [TBL] [Abstract][Full Text] [Related]
17. Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation. Zaru M; Sinico C; De Logu A; Caddeo C; Lai F; Manca ML; Fadda AM J Liposome Res; 2009; 19(1):68-76. PubMed ID: 19515009 [TBL] [Abstract][Full Text] [Related]
18. Liposome-encapsulated gentamicin treatment of Mycobacterium avium-Mycobacterium intracellulare complex bacteremia in AIDS patients. Nightingale SD; Saletan SL; Swenson CE; Lawrence AJ; Watson DA; Pilkiewicz FG; Silverman EG; Cal SX Antimicrob Agents Chemother; 1993 Sep; 37(9):1869-72. PubMed ID: 8239598 [TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity and clinical efficacy of sparfloxacin in Mycobacterium avium-intracellulare complex infection. Horiguchi T; Kondo R; Miyazaki J; Shiga M; Sugiyama M; Handa M; Munekata E J Int Med Res; 2004; 32(5):530-9. PubMed ID: 15458286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]